To investigate this hypothesis, the impact of inhibiting FOXO1 with AS1842856 (a small molecule inhibitor that binds/inactivates unphosphorylated FOXO1) was examined in BBC and GBM cells as a potential novel cancer chemotherapy. This evidence concerns the gene FOXO1 and glioblastoma.